U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07796997) titled 'GI-06: The Impact of Perioperative Hydrocortisone on Patients Undergoing Partial Pancreatectomy' on Aug. 27.
Brief Summary: This is a single-site, randomized, controlled treatment trial evaluating perioperative steroid hydrocortisone use in patients undergoing pancreatic resection (partial pancreatectomy). Eligible participants will be randomized to one of two arms: (1) perioperative hydrocortisone or (2) standard perioperative care. Participants randomized to the intervention arm will receive hydrocortisone 100 mg intravenously at the time of resection, followed by two additional 100 mg intravenous doses administered every 8 hours,...